-
-
A few years ago, cardiac stress testing would not have been an important subject for emergency physicians. With the growth of observation units run by emergency physicians, however, more of us are ordering these tests and then acting on the results.
-
This active, population-based, surveillance study was conducted by the CDC, in collaboration with state health departments and universities in 10 states participating in the Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network.
-
Over the past several years, Japan has been the chief source of measles importation into the United States. A total of 63 cases of measles were imported to the United States from Japan during the past 22 years.
-
Reduction of treatment-related toxicities have direct bearing on the decision when to initiate antiretroviral therapy. Clinicians may opt to delay antiretroviral therapy or avoid certain agents because of quality-of-life issues and the risk of treatment-related toxicity.
-
-
In This Issue: Baxter Bioscience has developed a whole-virus, two dose
vaccine against avian flu; warning label now on antipsychotics regarding an increased risk of mortality in elderly patients treated for dementia-related psychosis; vitamin D for men with heart disease on
horizon? A new oral anticoagulant may soon be available for prevention of thrombotic complications of hip or knee surgery; FDA Actions
-
As mentioned in the article by Russell et al, a patient was admitted to the hospital in the United Kingdom after a week's febrile respiratory illness; he had previously been in good health. Admission chest radiograph showed many nodules.
-
A cohort of 549 internationally adopted children greater than and equal to" 3 months of age (mean age, 22.9 months; range, 1.2 200 months) was evaluated at Cincinnati Children's Hospital between 1999 and 2004, with a post-adoption health visit within two months (mean, 12 days) after arrival in the United States.
-
In France, 750 patients from 12 hospitals participated in a concealed, randomized, multicenter, evaluator-blinded, parallel-group trial (the Cathedia study) conducted between 2004 and 2007.
